Skip to main content
OpenTrials

Clinical trial condition

TTR-mediated Amyloidosis

Explore clinical trials studying TTR-mediated Amyloidosis. Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

TTR-mediated Amyloidosis trial results

Completed

APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis

NCT01960348

Conditions
Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +16 more
Locations
  • Clinical Trial Site La Mesa, California, United States
  • Clinical Trial Site Orange, California, United States
  • Clinical Trial Site Denver, Colorado, United States
  • Clinical Trial Site Chicago, Illinois, United States
View all 52 locations
View Trial Details
Completed

The Study of ALN-TTR02 (Patisiran) for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran)

NCT01961921

Conditions
TTR-mediated Amyloidosis
Locations
  • Clinical Trial Site Boston, Massachusetts, United States
  • Clinical Trial Site Rio de Janeiro, Brazil
  • Clinical Trial Site Le Kremlin-Bicêtre, France
  • Clinical Trial Site Marseille, France
View Trial Details
Completed

A Extension Study to Evaluate Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Cardiac Amyloidosis

NCT02292186

Conditions
Alzheimer Disease, Brain Diseases, Cardiomyopathies, +11 more
Locations
  • Clinical Trial Site Boston, Massachusetts, United States
  • Clinical Trial Site New York, United States
  • Clinical Trial Site Cleveland, Ohio, United States
  • Clinical Trial Site Calgary, Alberta, Canada
View Trial Details

Related conditions